222 related articles for article (PubMed ID: 25242162)
1. Omalizumab in chronic urticaria: our experience and literature review.
Košnik M; Kopač P; Eržen R; Bajrović N; Adamič K; Lalek N; Korošec P; Zidarn M
Acta Dermatovenerol Alp Pannonica Adriat; 2014; 23(3):57-61. PubMed ID: 25242162
[TBL] [Abstract][Full Text] [Related]
2. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
Metz M; Ohanyan T; Church MK; Maurer M
J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
[TBL] [Abstract][Full Text] [Related]
3. Omalizumab in chronic urticaria: a retrospective series of 15 cases.
Armengot-Carbo M; Velasco-Pastor M; Rodrigo-Nicolas B; Pont-Sanjuan V; Quecedo-Estebanez E; Gimeno-Carpio E
Dermatol Ther; 2013; 26(3):257-9. PubMed ID: 23742285
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
Maurer M; Altrichter S; Bieber T; Biedermann T; Bräutigam M; Seyfried S; Brehler R; Grabbe J; Hunzelmann N; Jakob T; Jung A; Kleine-Tebbe J; Mempel M; Meurer M; Reich K; Ruëff F; Schäkel K; Sengupta K; Sieder C; Simon JC; Wedi B; Zuberbier T; Mahler V; Staubach P
J Allergy Clin Immunol; 2011 Jul; 128(1):202-209.e5. PubMed ID: 21636116
[TBL] [Abstract][Full Text] [Related]
5. The potential role of omalizumab in the treatment of chronic urticaria.
Stitt JM; Dreskin SC
Immunotherapy; 2014; 6(6):691-7. PubMed ID: 25186602
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of using omalizumab for more than 1 year in refractory chronic urticaria.
Har D; Patel S; Khan DA
Ann Allergy Asthma Immunol; 2015 Aug; 115(2):126-9. PubMed ID: 26093778
[TBL] [Abstract][Full Text] [Related]
7. [Omalizumab: therapeutic option in chronic spontaneous urticaria difficult to control with associated vasculitis, report of three cases].
Díez LS; Tamayo LM; Cardona R
Biomedica; 2013; 33(4):503-12. PubMed ID: 24652205
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
Maurer M; Rosén K; Hsieh HJ; Saini S; Grattan C; Gimenéz-Arnau A; Agarwal S; Doyle R; Canvin J; Kaplan A; Casale T
N Engl J Med; 2013 Mar; 368(10):924-35. PubMed ID: 23432142
[TBL] [Abstract][Full Text] [Related]
9. Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria.
Metz M; Ohanyan T; Church MK; Maurer M
JAMA Dermatol; 2014 Mar; 150(3):288-90. PubMed ID: 24477320
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.
Song CH; Stern S; Giruparajah M; Berlin N; Sussman GL
Ann Allergy Asthma Immunol; 2013 Feb; 110(2):113-7. PubMed ID: 23352531
[TBL] [Abstract][Full Text] [Related]
11. Chronic urticaria: omalizumab and review of therapeutic options.
Bergstrom KG
J Drugs Dermatol; 2013 Jun; 12(6):715-6. PubMed ID: 23839196
[TBL] [Abstract][Full Text] [Related]
12. Chronic idiopathic urticaria: treatment with omalizumab.
Naaman S; Sussman G
Skin Therapy Lett; 2014; 19(6):1-4. PubMed ID: 25807072
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
Kaplan A; Ledford D; Ashby M; Canvin J; Zazzali JL; Conner E; Veith J; Kamath N; Staubach P; Jakob T; Stirling RG; Kuna P; Berger W; Maurer M; Rosén K
J Allergy Clin Immunol; 2013 Jul; 132(1):101-9. PubMed ID: 23810097
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab: a review of its use in patients with chronic spontaneous urticaria.
McCormack PL
Drugs; 2014 Sep; 74(14):1693-9. PubMed ID: 25217402
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice.
Labrador-Horrillo M; Valero A; Velasco M; Jáuregui I; Sastre J; Bartra J; Silvestre JF; Ortiz de Frutos J; Gimenez-Arnau A; Ferrer M
Expert Opin Biol Ther; 2013 Sep; 13(9):1225-8. PubMed ID: 23875845
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Patients with Chronic Urticaria Who Responded and Did Not Respond to Omalizumab Treatment: A Single-Center Retrospective Study.
Cakmak ME
Int Arch Allergy Immunol; 2022; 183(11):1209-1215. PubMed ID: 36007494
[TBL] [Abstract][Full Text] [Related]
17. Omalizumab therapy in three patients with chronic autoimmune urticaria.
Al-Ahmad M
Ann Saudi Med; 2010; 30(6):478-81. PubMed ID: 20864790
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab for the treatment of chronic urticaria.
Zuberbier T; Maurer M
Expert Rev Clin Immunol; 2015 Feb; 11(2):171-80. PubMed ID: 25566680
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab in the treatment of chronic urticaria.
Francés L; Leiva-Salinas M; Silvestre JF
Actas Dermosifiliogr; 2014; 105(1):45-52. PubMed ID: 23938072
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab in chronic urticaria.
Metz M; Maurer M
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):406-11. PubMed ID: 22766620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
